Study #2022-0610
Evaluation of the response and non-response of Nirogacestat in desmoid tumors - Clinical Study
MD Anderson Study Status
Enrolling
Treatment Agent
Nirogacestat
Description
To learn about the safety and effects of an investigational drug called nirogacestat when given to participants with a desmoid tumor/aggressive fibromatosis
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Tumor
Study phase:
Phase II
Physician name:
Keila Torres
Department:
Surgical Oncology
For general questions about clinical trials:
1-866-403-3911
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.